MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ALLEVIATE-2 Phase 3 pivotal ...
Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate didn’t demonstrate sufficient efficacy in preventing invasive E. coli disease No safety signals ...
coli candidate, the asset has failed its phase 3 trial. A scheduled review by the study’s independent data monitoring committee (IDMC) had decided that the vaccine was “not sufficiently ...
The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...
The full result from Eisai’s large, global phase 3 confirmatory Clarity AD clinical study of lecanemab – an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of ...
Captain America: Brave New World marks the penultimate movie release of Phase 5 of the MCU which marks ... you might think this is Avengers 3, by the way, but it isn't. Cap's guys are variously ...
Blackwing Lair is the headline PVE activity in Phase 3 but before players can take on this level 60 raid and the 8 bosses within, they’ll need to complete a short attunement questline that takes them ...
Tom Boggioni is a writer, born, raised and living in San Diego — where he attended San Diego State University. Prior to writing for Raw Story, he wrote for FireDogLake, blogged as TBogg, and ...
Drugmakers Sanofi and Johnson & Johnson announced yesterday that they're pulling the plug on a phase 3 trial of their joint vaccine candidate for extraintestinal pathogenic Escherichia coli. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback